Skip to main navigation Investor FAQs Investor Relations Overview Press Releases Corporate Deck Events & Presentations Press Kit Corporate Governance Financial Info Stock Info Analyst Coverage Investor Resources Shareholder Services Investor FAQs Information Request Email Alerts Investor and Media Contacts Show all Where are Intellia's corporate headquarters and what is the telephone number? Intellia’s headquarters are located at 40 Erie Street, Suite 130 Cambridge, Massachusetts 02139 U.S. The main office phone number is (857) 285-6200. On which exchange is Intellia listed, what is its ticker symbol, and when did it go public? Intellia’s stock is traded on the NASDAQ Global Market under the symbol NTLA. The company’s initial public offering (IPO) was in May 2016. What is Intellia’s CUSIP number? Intellia’s CUSIP number is 45826J 105. Who is Intellia's transfer agent? Computershare Trust Company, Inc. 250 Royall Street Canton, MA 02021 US Phone: +1 800 962 4284 International Phone: +1 781 575 3120 Who is Intellia's independent auditor? Intellia’s independent auditor is: Deloitte & Touche LLP 200 Berkeley Street Boston, MA 02116 (617) 437-2000 How can I view documents Intellia has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q? Intellia’s SEC filings can be viewed on our under Financial Information or Where can I get the latest corporate news releases and financial reports? Intellia’s press release archives can be viewed on our Press Releases page by clicking Whom should I contact regarding investor inquiries? You can reach our IR team by contacting Info Overview Leadership Partners Healthcare Professionals Overview CRISPR/Cas9 What’s CRISPR/Cas9? How CRISPR/Cas9 Works Types of Edits Glossary Investors & Media Overview Press Releases Scientific Publications & Presentations Corporate Deck Events & Presentations Press Kit Programs & Pipeline Our Full-Spectrum Approach Pipeline In Vivo Therapies Ex Vivo Therapies Careers Overview Patients & Families Our Commitment Clinical Trials Community Perspective & Resources Expanded Access Policy © Intellia Therapeutics 2021 Cookie Policy Terms of Use Privacy Policy Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.